The panel (HSP70, GPC3, and GS) demonstrated 100% specificity for HCC detection when ≥2 markers were positive, with sensitivity increasing from 23.5% in VWD-HCC to 74% in MPD-HCC [81]. The gene discussed is GPC3; the disease is hepatocellular carcinoma.